Chemclin Diagnostics Co., Ltd.
Status: Publicly traded
Direct answer
Chemclin Diagnostics Co., Ltd. is publicly traded on SHH under the ticker 688468.SS.
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B,...
Can you invest in Chemclin Diagnostics Co., Ltd.?
Yes. Chemclin Diagnostics Co., Ltd. is publicly traded on SHH under the ticker 688468.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Chemclin Diagnostics Co., Ltd.
Detailed equity research is provided by MarketSnap.